The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global blood collection market was valued at US$ 6.2 Billion in 2021.
We expect the global blood collection market to exhibit a CAGR of 5.94% during 2022-2027.
The sudden outbreak of the COVID-19 pandemic has led to the rising demand for blood collection through blood donations for providing blood/plasma transfusion to the coronavirus-infected patients with weak immune systems.
The growing cases of several chronic and lifestyle diseases, along with the increasing number of accidents and surgical procedures performed in hospitals, are primarily driving the global blood collection market.
Based on the product, the global blood collection market can be segmented into needles and syringes, blood collection tubes, blood bags and others. Currently, needles and syringes hold the majority of the total market share.
Based on the application, the global blood collection market has been bifurcated into diagnostics and treatment, where diagnostics currently exhibit a clear dominance in the market.
Based on the end use, the global blood collection market can be divided into hospitals, diagnostics centers, blood banks, and others. Among these, hospitals account for the largest market share.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global blood collection market include Abbott Laboratories, Becton Dickinson and Company, FL MEDICAL s.r.l., Greiner AG, Haemonetics Corporation, McKesson Corporation, Medtronic plc, Nipro Corporation, Qiagen N.V., Quest Diagnostics, Sarstedt AG & Co. KG, and Terumo Corporation.
Epilepsy Drugs Market by Generation Type (First Generation Drugs, Second Generation Drugs, Third Generation Drugs), Anti-Epileptics Drugs Type (Narrow-Spectrum AEDs, Broad-Spectrum AEDs), Distribution Channel (Hospital Pharmacy, Pharmacy Stores, and Others), and Region 2023-2028
Congestive Heart Failure Drugs Market by Drug Class (ACE Inhibitors, Angiotensin 2 Receptor Blockers, Beta Blockers, Diuretics, Aldosterone Antagonists, Inotropes, and Others), Route of Administration (Oral, Intravenous), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2023-2028
Gastric Cancer Drugs Market by Type (Doxorubicin Hydrochloride, Sunitinib, Docetaxel, Mitomycin, Fluorouracil, Imatinib, Trastuzumab), Route of Administration (Oral, Parenteral), End User (Hospitals, Clinics, and Others), and Region 2023-2028
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at